G57321FI
| Organisms | Evidence |
|---|---|
| Ovis aries (sheep) | |
| Cricetulus griseus (Chinese hamster) | |
| Mus musculus (house mouse) | |
| Bos taurus (domestic cattle) | |
| Escherichia coli |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
| ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
| ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
| B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
| ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
| ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
| ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
| ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
|---|---|---|---|---|
| ST6GALNAC3 | CMP-Neu5Ac |
|
Ser/Thr | |
| ST6GAL2 | CMP-Neu5Ac |
|
para-nitrophenol | |
| ST6GALNAC2 | CMP-Neu5Ac |
|
benzyl | |
| ST6GALNAC1 | CMP-Neu5Ac |
|
[alpha]-Bz | |
| ST6GALNAC2 | CMP-Neu5Ac |
|
Ser/Thr |
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| Q9Y2G1 | Myelin regulatory factor | ||
| Q9Y4C4 | Malignant fibrous histiocytoma-amplified sequence 1 | ||
| Q9Y4L1 | Hypoxia up-regulated protein 1 | ||
| Q9Y520 | Protein PRRC2C | ||
| Q9Y5L2 | Hypoxia-inducible lipid droplet-associated protein | ||
| Q9Y5M8 | Signal recognition particle receptor subunit beta | ||
| Q9Y5T4 | DnaJ homolog subfamily C member 15 | ||
| Q9Y5X9 | Endothelial lipase | ||
| Q9Y5Y6 | Suppressor of tumorigenicity 14 protein | ||
| Q9Y5Z0 | Beta-secretase 2 |
| Pathway Name | Organism |
|---|---|
| Lectin pathway of complement activation | Bos taurus |
| Lectin pathway of complement activation | Rattus norvegicus |
| Lectin pathway of complement activation | Mus musculus |
| Lectin pathway of complement activation | Homo sapiens |
| Lectin pathway of complement activation | Xenopus tropicalis |
| Lectin pathway of complement activation | Gallus gallus |
| Lectin pathway of complement activation | Canis familiaris |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 36293310 | Mutation Hotspot for Changing the Substrate Specificity of β-N-Acetylhexosaminidase: A Library of GlcNAcases | Nekvasilová P | 2022 Oct 18 |
|
| 36094307 | Disruption of the tagF Orthologue in the epa Locus Variable Region of Enterococcus faecalis Causes Cell Surface Changes and Suppresses an eep -Dependent Lysozyme Resistance Phenotype | Rouchon CN | 2022 Oct 18 |
|
| 35987426 | Differential expression of glycans in the urothelial layers of horse urinary bladder | Desantis S | 2022 Oct |
|
| 36253014 | Metabolomic markers of glucose regulation after a lifestyle intervention in prediabetes | Sevilla-Gonzalez MDR | 2022 Oct |
|
| 36041884 | Plasma and Liver Pharmacokinetics of the N-Acetylgalactosamine Short Interfering RNA JNJ-73763989 in Recombinant Adeno-Associated–Hepatitis B Virus–Infected Mice | Sandra L | 2022 Oct |
|
| 35907378 | Mn-doped bimetallic synergistic catalysis boosts for enzymatic phosphorylation of N-Acetylglucosamine/ N-Acetylgalactosamine and their derivatives | Xu H | 2022 Nov |
|
| 35618750 | Author Correction: The Pel polysaccharide is predominantly composed of a dimeric repeat of α-1,4 linked galactosamine and N-acetylgalactosamine | Le Mauff F | 2022 May 26 |
|
| 35504880 | Structural basis for the synthesis of the core 1 structure by C1GalT1 | González-Ramírez AM | 2022 May 03 |
|
| 35321541 | Protein Engineering of PhUGT, a Donor Promiscuous Glycosyltransferase, for the Improved Enzymatic Synthesis of Antioxidant Quercetin 3-O-N-Acetylgalactosamine | Xu Z | 2022 Mar 24 |
|
| 35151686 | Loss of the N-acetylgalactosamine side chain of the GPI-anchor impairs bone formation and brain functions and accelerates the prion disease pathology | Hirata T | 2022 Mar |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025